Clinical TrialsSearch results
Number of results: 395
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- A Phase II Study of carboplatin plus paclitaxel for advanced thymic cancer
- Thymic cancer
- West Japan Oncology Group
- 2008-09-08
Other
- A phase II study of Irinotecan (CPT-11) for Leiomyosarcoma of Uterus
- Leiomyosarcoma of Uterus
- Japanese Gynecologic Oncology Group
- 2006-07-13
Other
- A phase II study of percutaneous radiofrequency ablation for malignant lung tumor (JIVROSG-0702)
- Malignant lung tumor
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2008-11-12
Other
- A phase II study of percutaneous radiofrequency ablation for malignant reanl tumor (JIVROSG-0701)
- malignant renal tumor
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2008-04-22
Other
- A phase II study of the combination of Rituximab, Mitoxantrone, Etoposide, and Prednisolone for relapsed elderly patients with diffuse large B-cell lymphoma (R-MEP07)
- Diffuse large B-cell lymphoma
- Clinical Hematology Study Group of National Hospital Organization (CHSG-NHO)
- 2008-03-01
Other
- A phase II study of the remission induction and maintenance therapy by rituximab for rituximab naive low grade B cell lymphoma.
- low grade B cell lymphoma
- Clinical Hematology Study Group of National Hospital Organization(CHSG-NHO)
- 2008-06-20
Other
- A Phase II Trial of Gefitinib Monotherapy in Elderly Chemo-naïve Patients with Advanced Non–Small Cell Lung Cancer
- Non small cell lung cancer
- LOGIK
- 2005-09-06
Other
- A phase II/III clinical study of R442(Pegylated Interferon alfa-2a) for patients with chronic hepatitis B.
- chronic hepatitis B
- CHUGAI PHARMACEUTICAL CO.LTD.
- 2007-04-26
Other
- A phase III randomised trial of lobectomy versus limited resection (segmentectomy) for small (2 cm or less) peripheral non-small cell lung cancer (JCOG0802/WJOG4607L)
- small (2 cm or less) peripheral non-small cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2009-08-10
Other
- A Phase III Randomized, Multicenter Study Comparing Irinotevan and Cisplatin (IP) with Amrubicin and Cisplatin (AP) for the Treatment of Extensive-Stage Small-Cell Lung Cancer: (JCOG0509)
- extensive-disease small cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2007-05-22